About ClexBio

ClexBio is a pre-clinical stage regenerative medicine company that has developed a ground-breaking proprietary technology platform for scalable, high-throughput tissue generation. ClexBio holds patents for a highly innovative method for producing biocompatible hydrogels, as well as the technology for growing large tissues from healthy human cells in complex geometric shapes.

Company Highlights
Year Founded

2020

icon-altEmployees

12

Location (HQ)

NOR

Since Last Funding

1 year 8 months

Monthly Website Visitors

1.9K

icon-altTotal Investment Amt

$2.2M

Last Funding Round

Series Unknown

Key Metrics

Senior Hires

NameLinkedin ProfilePositionDate Joined
John Doehttps://www.linkedin.com/in/johndoeCEOCEO
Jane Doehttps://www.linkedin.com/in/janedoeCTOCTO
John Smithhttps://www.linkedin.com/in/johnsmithCFOCFO
Jane Smithhttps://www.linkedin.com/in/janesmithCOOCOO
Get API access to complete private company database with growth metrics from 15 sources

Biotechnology Research

Health Care

Biotechnology